Joshua Bauer
Joshua Bauer
Research Assistant Professor of Biochemistry, Vanderbilt University
Подтвержден адрес электронной почты в домене
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
BD Lehmann, JA Bauer, X Chen, ME Sanders, AB Chakravarthy, Y Shyr, ...
The Journal of clinical investigation 121 (7), 2750-2767, 2011
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer
B Kumar, KG Cordell, JS Lee, FP Worden, ME Prince, HH Tran, GT Wolf, ...
Journal of clinical oncology: official journal of the American Society of …, 2008
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets
JM Balko, JM Giltnane, K Wang, LJ Schwarz, CD Young, RS Cook, ...
Cancer discovery 4 (2), 232-245, 2014
PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
BD Lehmann, JA Bauer, JM Schafer, CS Pendleton, L Tang, KC Johnson, ...
Breast Cancer Research 16 (4), 1-14, 2014
TNBCtype: a subtyping tool for triple-negative breast cancer
X Chen, J Li, WH Gray, BD Lehmann, JA Bauer, Y Shyr, JA Pietenpol
Cancer informatics 11, CIN. S9983, 2012
Identification of markers of taxane sensitivity using proteomic and genomic analyses of breast tumors from patients receiving neoadjuvant paclitaxel and radiation
JA Bauer, AB Chakravarthy, JM Rosenbluth, D Mi, EH Seeley, ...
Clinical Cancer Research 16 (2), 681-690, 2010
A novel BH3 mimetic reveals a mitogen-activated protein kinase–dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species
M Verhaegen, JA Bauer, CM de la Vega, G Wang, KG Wolter, JC Brenner, ...
Cancer research 66 (23), 11348-11359, 2006
In vitro effects of the BH3 mimetic,(−)-gossypol, on head and neck squamous cell carcinoma cells
CL Oliver, JA Bauer, KG Wolter, ML Ubell, A Narayan, KM O’Connell, ...
Clinical cancer research 10 (22), 7757-7763, 2004
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer
L Formisano, Y Lu, A Servetto, AB Hanker, VM Jansen, JA Bauer, ...
Nature communications 10 (1), 1-14, 2019
Reversal of cisplatin resistance with a BH3 mimetic,(−)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL
JA Bauer, DK Trask, B Kumar, G Los, J Castro, JSJ Lee, J Chen, S Wang, ...
Molecular cancer therapeutics 4 (7), 1096-1104, 2005
Kinome-wide RNA interference screen reveals a role for PDK1 in acquired resistance to CDK4/6 inhibition in ER-positive breast cancer
VM Jansen, NE Bhola, JA Bauer, L Formisano, KM Lee, KE Hutchinson, ...
Cancer research 77 (9), 2488-2499, 2017
Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer
S Shangary, K Ding, S Qiu, Z Nikolovska-Coleska, JA Bauer, M Liu, ...
Molecular cancer therapeutics 7 (6), 1533-1542, 2008
RNA interference (RNAi) screening approach identifies agents that enhance paclitaxel activity in breast cancer cells
JA Bauer, F Ye, CB Marshall, BD Lehmann, CS Pendleton, Y Shyr, ...
Breast Cancer Research 12 (3), 1-16, 2010
SFK/FAK signaling attenuates osimertinib efficacy in both drug-sensitive and drug-resistant models of EGFR-mutant lung cancer
E Ichihara, D Westover, CB Meador, Y Yan, JA Bauer, P Lu, F Ye, A Kulick, ...
Cancer research 77 (11), 2990-3000, 2017
Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival
S Adams, AB Chakravarthy, M Donach, D Spicer, S Lymberis, B Singh, ...
Breast cancer research and treatment 124 (3), 723-732, 2010
Comparative study of exome copy number variation estimation tools using array comparative genomic hybridization as control
Y Guo, Q Sheng, DC Samuels, B Lehmann, JA Bauer, J Pietenpol, Y Shyr
BioMed research international 2013, 2013
Quantifying drug combination synergy along potency and efficacy axes
CT Meyer, DJ Wooten, BB Paudel, J Bauer, KN Hardeman, D Westover, ...
Cell systems 8 (2), 97-108. e16, 2019
Cellular manganese content is developmentally regulated in human dopaminergic neurons
KK Kumar, EW Lowe Jr, AA Aboud, MD Neely, R Redha, JA Bauer, ...
Scientific reports 4 (1), 1-8, 2014
Antagonism of the sodium-potassium ATPase impairs chikungunya virus infection
AW Ashbrook, AJ Lentscher, PF Zamora, LA Silva, NA May, JA Bauer, ...
MBio 7 (3), e00693-16, 2016
Growth inhibition and differentiation in human prostate carcinoma cells induced by the vitamin D analog 1α, 24‐dihydroxyvitamin D2
JA Bauer, TA Thompson, DR Church, EA Ariazi, G Wilding
The Prostate 55 (3), 159-167, 2003
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20